BACKGROUND Poor growth is an indication for antiretroviral therapy (ART) and a criterion for treatment failure. We examined variability in growth response to ART in 12 programs in Ma...
Fenner L, Brinkhof MW, Keiser O, Weigel R, Cornell M, et al.
2010-08-01 • Journal of Acquired Immune Deficiency Syndromes (1999)
2010-08-01 • Journal of Acquired Immune Deficiency Syndromes (1999)
BACKGROUND: Many HIV-infected children in Southern Africa have been started on antiretroviral therapy (ART), but loss to follow up (LTFU) can be substantial. We analyzed mortality in chi...
Makombe SD, Harries AD, Yu JKL, Hochgesang M, Mhango E, et al.
2007-04-01 • International Journal of Tuberculosis and Lung Disease
2007-04-01 • International Journal of Tuberculosis and Lung Disease
SETTING: Public sector facilities in Malawi providing antiretroviral therapy (ART) to human immunodeficiency virus (HIV) positive patients, including those with tuberculosis (TB). OBJECT...
Egger M, Sidle J, Weigel R, Geng EH, Fox MP, et al.
2011-01-01 • PLOS Medicine
2011-01-01 • PLOS Medicine
The World Health Organization estimates that in sub-Saharan Africa about 4 million HIV-infected patients had started antiretroviral therapy (ART) by the end of 2008. Loss of patients to ...
Makombe SD, Harries AD, Yu JKL, Hochgesang M, Mhango E, et al.
2008-01-01 • Tropical Doctor
2008-01-01 • Tropical Doctor
AIDS-associated Kaposi's sarcoma (KS) is the most common AIDS-related malignancy in sub-Saharan Africa, with a generally unfavourable prognosis. We report on six-month and 12-month cohor...
